Becton, Dickinson and Company BDX, popularly known as BD, recently announced the expansion of its partnership with Ypsomed to ...

The new 5.5ml BD Neopak XtraFlow Syringe uses BD’s advanced technologies, including thinner cannulas.

BD and Ypsomed will expand their collaboration through the development of a 5.5 ml version of BD’s Neopak XtraFlow glass ...

The 5.5mL version of the BD Neopak XtraFlow syringe is fully compatible with Ypsomed’s YpsoMate 5.5 autoinjector platform.

The collaboration between ten23 health and BD aims to commercialize the BD Libertas wearable injector for large-volume ...

LE PONT-DE-CLAIX, France, Sept. 18, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the commercial release of the BD Neopak™ ...

BD said it will spend approximately $60 million on the 69,000-square-foot expansion and upgrade of the plant, which it wants to transform into “one of the largest and most sophisticated plastic ...

FRANKLIN LAKES, N.J., June 8, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has received pandemic orders for ...

Global Self-Injection Systems Market Trends 2023: This research elaborates on the industrial trends for topmost industries for the insights on Self-Injection Systems market, observes modifications in ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Ypsomed, a leading developer of injection systems, are strengthening their collaboration with the ...